|
Lenalidomide Impurity 57
|
來那度胺雜質 57
|
77324-87-9
|
|
Linagliptin Impurity 66
|
利格列汀雜質 66
|
668273-75-4
|
|
Lenalidomide Impurity 56
|
來那度胺雜質 56
|
2197414-57-4
|
|
Lamivudine Impurity 21
|
恩曲他濱雜質24
|
147027-10-9
|
|
Lincomycin Hydrochloride EP Impurity C
|
林可霉素EP雜質C；N-去甲基林可霉素
|
14600-41-0
|
|
Linagliptin Impurity G
|
利格列汀雜質G
|
668270-11-9
|
|
Linagliptin Impurity 68
|
利格列汀雜質 68
|
1643364-41-3
|
|
Linagliptin Impurity N
|
利格列汀雜質 N
|
2416949-69-2
|
|
Linagliptin Impurity E
|
利格列汀雜質E
|
1446263-38-2
|
|
Linagliptin
|
利格列汀
|
668270-12-0
|
|
Lenalidomide Impurity C
|
來那度胺雜質C
|
2197420-75-8
|
|
Lenalidomide Impurity B
|
來那度胺雜質B
|
1218910-61-2
|
|
Lenalidomide
|
來那度胺
|
191732-72-6
|
|
Linagliptin Acetamide
|
利格列汀乙酰胺
|
1803079-49-3
|
|
Lamivudine EP Impurity H
|
拉米夫定EP雜質H
|
160552-54-5
|
|
Lamivudine EP Impurity J
|
拉米夫定EP雜質J
|
145986-07-8
|
|
Lamivudine EP Impurity I
|
拉米夫定 EPI
|
145918-75-8
|
|
Lamivudine Impurity 1
|
拉米夫定雜質 1
|
136846-20-3
|
|
Lenalidomide Impurity 46
|
來那度胺雜質 46
|
98475-07-1
|
|
Lenalidomide Impurity 43
|
來那度胺雜質 43
|
2197414-56-3
|
|
Linagliptin Impurity T(Linagliptin Methyldimer)
|
利格列汀雜質T（利格列汀甲基二聚體）
|
1418133-47-7
|
|
Linagliptin Impurity R
|
利格列汀雜質R
|
1646355-34-1
|
|
(R)-(+)-Limonene
|
（R） -（+）-檸檬烯
|
5989-27-5
|
|
Levetiracetam EP Impurity C
|
左乙拉西坦EP雜質C
|
142-08-5
|
|
Levosimendan Impurity 6
|
左西孟旦雜質 6
|
101328-85-2
|
|
Levofloxacin EP Impurity B; Levofloxacin Related Compound A
|
左氧氟沙星EP雜質B；左氧氟沙星相關化合物A
|
117707-40-1
|
|
Lafutidine Impurity 13
|
拉夫替丁雜質 13
|
103922-84-5
|
|
Lafutidine Sulfone
|
拉夫替丁砜
|
174583-84-7
|
|
Lafutidine Phthalimide Impurity
|
拉夫替丁鄰苯二甲酰亞胺雜質
|
146447-26-9
|
|
Levodropropizine EP Impurity B
|
N-苯基哌嗪
|
92-54-6
|
|
Levocetirizine Impurity 2
|
左西替利嗪雜質2
|
300543-56-0
|
|
Levocetirizine Impuritya; USP Levocetirizine Amide
|
左西替利嗪雜質A；USP左西替利嗪酰胺
|
909779-33-5
|
|
Leuprolide(Leuprorelin) EP Impurity I
|
亮丙瑞林EP雜質I
|
1926163-26-9
|
|
Levofloxacin EP Impurity F; USP Levofloxacin Related Compound B
|
左氧氟沙星 EPF；USP 左氧氟沙星相關化合物 B
|
100986-89-8
|
|
Levofloxacin EP Impurity H; USP Levofloxacin Related Compound C
|
左氧氟沙星 EPH；USP 左氧氟沙星相關化合物 C
|
177472-30-9
|
|
Lipoic Acid Impurity 24
|
硫辛酸雜質 24
|
50628-92-7
|
|
Lipoic Acid Impurity 33
|
硫辛酸雜質 33
|
188745-24-6
|
|
Lipoic Acid Impurity 36
|
硫辛酸雜質 36
|
188783-96-2
|
|
Levofloxacin Desethylene Diformyl Impurity
|
左氧氟沙星脫乙二甲?；s質
|
151377-74-1
|
|
Levofloxacin EP Impurity I
|
左氧氟沙星EP雜質I
|
178912-62-4
|
|
Levofloxacin Impurity N
|
左氧氟沙星雜質N
|
1026952-91-9
|
|
Levofloxacin Impurity 7
|
左氧氟沙星雜質7
|
117678-37-2
|
|
Levofloxacin Impurity 10
|
左氧氟沙星雜質10
|
106939-34-8
|
|
Levofloxacin Impurity 19
|
左氧氟沙星雜質 19
|
1797510-34-9
|
|
Levofloxacin Impurity 6
|
左氧氟沙星雜質 37
|
1329833-82-0
|
|
Levofloxacin EP Impurity C; USP Levofloxacin Related Compound C
|
左氧氟沙星EP雜質C；USP左氧氟沙星相關化合物C
|
117678-38-3
|
|
Lipoic Acid Impurity 4
|
硫辛酸雜質 4
|
17370-41-1
|
|
Lipoic Acid Impurity 34
|
硫辛酸雜質 34
|
2635383-46-7
|
|
Levofloxacin Impurity 22
|
左氧氟沙星雜質22
|
177472-29-6
|
|
Levofloxacin EP Impurity G; USP Levofloxacin Related Compound E
|
左氧氟沙星EP雜質G；左氧氟沙星USP相關化合物E
|
151250-76-9
|
|
Levofloxacin EP Impurity E
|
左氧氟沙星EP雜質E
|
178964-53-9
|
|
Levofloxacin EP Impurity D; USP Levofloxacin Related Compound F
|
左氧氟沙星 EPD；USP 左氧氟沙星相關化合物 F
|
117620-85-6
|
|
Levofloxacin EP Impurity A; R-Ofloxacin
|
左氧氟沙星 EPA;R-氧氟沙星
|
100986-86-5
|
|
Eslicarbazepine Acetate
|
醋酸艾司利卡西平
|
236395-14-5
|
|
Licarbazepine
|
利卡西平
|
29331-92-8
|
|
Liraglutide
|
利拉魯肽
|
204656-20-2
|
|
Leuprolide(Leuprorelin) EP Impurity H
|
亮丙瑞林EP雜質H
|
112710-58-4
|
|
Leuprolide(Leuprorelin) EP Impurity G
|
亮丙瑞林EP雜質G
|
112710-57-3
|
|
Leuprolide(Leuprorelin) EP Impurity F
|
亮丙瑞林EP雜質F
|
1872435-00-1
|
|
Leuprolide(Leuprorelin) EP Impurity E
|
亮丙瑞林EP雜質E
|
1926163-23-6
|
|
Leuprolide(Leuprorelin) EP Impurity D
|
亮丙瑞林EP雜質D
|
1926163-25-8
|
|
Leuprolide(Leuprorelin) EP Impurity C
|
亮丙瑞林EP雜質C
|
54785-87-4
|
|
Leuprolide(Leuprorelin) EP Impurity B
|
亮丙瑞林EP雜質B
|
112642-11-2
|
|
Leuprolide(Leuprorelin) EP Impurity A
|
亮丙瑞林EP雜質A
|
62621-13-0
|
|
Lipoic Acid Impurity 22
|
硫辛酸雜質 22
|
25636-58-2
|
|
Lipoic Acid Impurity 3; Rac-Lipoic Acid Impurity 1 (S-Oxide)
|
硫辛酸雜質 3
|
108015-78-7
|
|
Lipoic Acid Impurity A
|
硫辛酸雜質A
|
728854-75-9
|
|
Lifitegrast Impurity 32
|
立他司特雜質32
|
1289646-90-7
|
|
Lifitegrast Impurity 12
|
立他司特雜質12
|
77095-51-3
|
|
Lifitegrast Impurity 5
|
立他司特雜質5
|
2271299-08-0
|
|
Lifitegrast
|
立他司特
|
1025967-78-5
|
|
Lamivudine EP Impurity D
|
拉米夫定EP雜質D
|
134680-32-3
|
|
Lamivudine EP Impurity E; Gemcitabine EP Impurity A
|
拉米夫定 EPE；吉西他濱 EPA
|
71-30-7
|
|
Lamivudine EP Impurity G
|
拉米夫定EP雜質G
|
160552-55-6
|
|
Lansoprazole EP Impurity C
|
蘭索拉唑EP雜質C
|
103577-40-8
|
|
Lansoprazole Impurity K(Lansoprazole Sulfide N-Oxide)
|
蘭索拉唑雜質K（蘭索拉唑硫化物N-氧化物）
|
163119-30-0
|
|
Levetiracetam EP Impurity B
|
左乙拉西坦EP雜質B
|
358629-47-7
|
|
Lipoic Acid Impurity 11 (Impurity D)
|
硫辛酸雜質 11
|
2114407-76-8
|
|
Levetiracetam USP Rc A
|
左乙拉西坦 USP RC A
|
102767-31-7
|
|
Levosimendan Cyanoacetamide Hydrazone Impurity
|
左西孟旦雜質 8
|
274263-65-9
|
|
Lansoprazole Impurity 3
|
蘭索拉唑雜質3
|
1083100-27-9
|
|
Levetiracetam Carboxylic Acid
|
左乙拉西坦羧酸
|
102849-49-0
|
|
Levosimendan Impurity 3
|
左西孟旦雜質 12
|
618458-79-0
|
|
Levetiracetam EP Impurity A
|
左乙拉西坦EP雜質A
|
67118-31-4
|
|
Lansoprazole Sulfone N-Oxide
|
蘭索拉唑楓氮氧化物
|
953787-54-7
|
|
Levetiracetam
|
左乙拉西坦
|
102767-28-2
|
|
Levosimendan
|
左西孟旦
|
141505-33-1
|
|
Lansoprazole Impurity P
|
蘭索拉唑雜質P
|
1083100-26-8
|
|
Lomefloxacin Impurity 1
|
洛美沙星雜質1
|
195259-11-1
|
|
Levosimendan Impurity 14
|
左西孟旦雜質 14
|
252638-01-0
|
|
Levosimendan Impurity 24
|
左西孟旦雜質24
|
131741-08-7
|
|
Levetiracetam Impurity 6
|
左乙拉西坦雜質 6
|
1867585-44-1
|
|
Levetiracetam Impurity 14
|
左乙拉西坦雜質 14
|
1868118-63-1
|
|
Lincomycin Hydrochloride EP Impurity F
|
鹽酸林可霉素EP雜質F
|
14810-93-6
|
|
Levetiracetam Impurity 2
|
左乙拉西坦雜質2
|
33996-58-6
|
|
Levetiracetam EP Impurity D
|
左乙拉西坦EP雜質D
|
103765-01-1
|
|
Levetiracetam USP Rc B
|
左乙拉西坦雜質U
|
7324-11-0
|
|
Linezolid Impurity 38
|
利奈唑胺雜質38
|
1219708-30-1
|
|
Lansoprazole Impurity 1
|
蘭索拉唑雜質1
|
163119-28-6
|
|
Levosimendan Impurity 11
|
左西孟旦雜質 11
|
144238-75-5
|